Clinical Trial Update: Clinical Study of R744 to Predialysis Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical study of R744 in pre-dialysis patients with anemia has completed. Sponsor: Chugai Pharmaceutical.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease

Drugs mentioned

• R744

Snippet

Sponsor: Chugai Pharmaceutical | Conditions: Anemia in Pre-Dialysis Patients | Phase 3 | Status: COMPLETED